Contrast Enhancement on Cone-Beam Breast-CT for Discrimination of Breast Cancer Immunohistochemical Subtypes.

Abstract:

PURPOSE:To evaluate whether contrast enhancement on cone-beam breast-CT (CBBCT) could aid in discrimination of breast cancer subtypes and receptor status. METHODS:This study included female patients age >40 years with malignant breast lesions identified on contrast-enhanced CBBCT. Contrast enhancement of malignant breast lesions was standardized to breast fat tissue contrast enhancement. All breast lesions were approved via image-guided biopsy or surgery. Immunohistochemical staining was conducted for expression of estrogen (ER), progesterone (PR), human epidermal growth factor receptor-2 (HER2) and Ki-67 index. Contrast enhancement of breast lesions was correlated with immunohistochemical breast cancer subtypes (Luminal A, Luminal B, HER2 positive, triple negative), receptor status and Ki-67 expression. RESULTS:Highest contrast enhancement was seen for Luminal A lesions (93.6 HU) compared to Luminal B lesions (47.6 HU, P=.002), HER2 positive lesions (83.5 HU, P=.359) and triple negative lesions (45.3 HU, P=.005). Contrast enhancement of HER2 positive lesions was higher than Luminal B lesions (P=.044) and triple negative lesions (P=.039). No significant difference was evident between Luminal B and triple negative lesions (P=.439). Lesions with high Ki-67 index showed lower contrast enhancement than those with low Ki-67 index (P=.0043). ER, PR and HER2 positive lesions demonstrated higher contrast enhancement than their receptor negative counterparts, although differences did not reach statistical significance (P=.1714; P=.3603; P=.2166). CONCLUSIONS:Contrast enhancement of malignant breast lesions on CBBCT correlates with immunohistochemical subtype and proliferative potential. Thereby, CBBCT might aid in selecting individualized treatment strategies for breast cancer patients based on pre-operative imaging.

journal_name

Transl Oncol

journal_title

Translational oncology

authors

Uhlig J,Fischer U,von Fintel E,Stahnke V,Perske C,Lotz J,Wienbeck S

doi

10.1016/j.tranon.2017.08.010

subject

Has Abstract

pub_date

2017-12-01 00:00:00

pages

904-910

issue

6

issn

1936-5233

pii

S1936-5233(17)30295-4

journal_volume

10

pub_type

杂志文章
  • Role of IGF-1 receptor in radiation response.

    abstract::Insulin-like growth factor 1 receptor (IGF-1R) is a transmembrane receptor tyrosine kinase involved in the development and progression of cancer whose activation strongly promotes cell growth and survival. IGF-1R exerts its main actions through the activation of the mitogen-activated protein kinase and phosphoinositid...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.11265

    authors: Valenciano A,Henríquez-Hernández LA,Moreno M,Lloret M,Lara PC

    更新日期:2012-02-01 00:00:00

  • Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer.

    abstract::Several data support a central role for angiogenesis in breast cancer growth and metastasis. Observational studies have demonstrated that microvascular density (MVD) is a prognostic factor in invasive breast cancer, whereas others reached the opposite conclusion. Vascular endothelial growth factor is the most importan...

    journal_title:Translational oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.tranon.2016.07.002

    authors: Ribatti D,Nico B,Ruggieri S,Tamma R,Simone G,Mangia A

    更新日期:2016-10-01 00:00:00

  • Pathological Pattern of Intrahepatic HBV in HCC is Phenocopied by PDX-Derived Mice: a Novel Model for Antiviral Treatment.

    abstract:BACKGROUND:Hepatitis B virus (HBV) is one of the most prominent risk factors for hepatocellular carcinoma (HCC) development and virus-mediated cases represents more than 80% of HCC in East Asia, where it is endemic. Currently, the HBV status of pathological HCC is not fully clarified, especially by comparison to nontum...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2019.05.006

    authors: Liu J,Chen S,Zou Z,Tan D,Liu X,Wang X

    更新日期:2019-09-01 00:00:00

  • Focal adhesion kinase functions as an akt downstream target in migration of colorectal cancer cells.

    abstract::Migration is a complex process that, besides its various physiological functions in embryogenesis and adult tissues, plays a crucial role in cancer cell invasion and metastasis. The focus of this study is the involvement and collaboration of Akt, focal adhesion kinase (FAK), and Src kinases in migration and invasivene...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.09160

    authors: Turecková J,Vojtechová M,Krausová M,Sloncová E,Korínek V

    更新日期:2009-12-01 00:00:00

  • Concurrent Chemoradiotherapy With or Without Induction Chemotherapy for Patients with Stage II Nasopharyngeal Carcinoma: An Update.

    abstract:PURPOSE:In contrast to other studies, our previous study showed that adding induction chemotherapy (IC) to concurrent chemoradiotherapy (CCRT) significantly worsened the prognosis of patients with stage II nasopharyngeal carcinoma (NPC). However, the population used was small; therefore, there is an urgent need to conf...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2019.08.007

    authors: Jin T,Zhang Q,Luo DH,Jiang F,Jin QF,Chen YY,Chen XZ,Mao WM

    更新日期:2020-01-01 00:00:00

  • Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer.

    abstract::Tumor hypoxia contributes to therapy resistance and metastatic progression of locally advanced rectal cancer (LARC). We postulated that the tumor mitochondrial metabolism, manifested by reactive oxygen species (ROS) and mitochondrial DNA (mtDNA) damage, reflects how hypoxic conditions connect to cancer-induced systemi...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.09.010

    authors: Bousquet PA,Meltzer S,Sønstevold L,Esbensen Y,Dueland S,Flatmark K,Sitter B,Bathen TF,Seierstad T,Redalen KR,Eide L,Ree AH

    更新日期:2019-01-01 00:00:00

  • Control of Glycolytic Flux by AMP-Activated Protein Kinase in Tumor Cells Adapted to Low pH.

    abstract::Tumor cells grow in nutrient- and oxygen-deprived microenvironments and adapt to the suboptimal growth conditions by altering their metabolic pathways. This adaptation process commonly results in a tumor phenotype that displays a high rate of aerobic glycolysis and aggressive tumor characteristics. The glucose regulat...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.11319

    authors: Mendoza EE,Pocceschi MG,Kong X,Leeper DB,Caro J,Limesand KH,Burd R

    更新日期:2012-06-01 00:00:00

  • Protein anabolism is key to long-term survival in high-grade serous ovarian cancer.

    abstract::This study aimed to identify the biological processes associated with long-term survival in high-grade serous ovarian cancer (HGSOC). HGSOC cases obtained from The Cancer Genome Atlas Ovarian Cancer (TCGA-OV) database were divided into long-term survivors (LTS) and normal-term survivors (NTS) based on survival cutoffs...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100885

    authors: Wang L,Sun T,Li S,Zhang Z,Jia J,Shan B

    更新日期:2021-01-01 00:00:00

  • CHFR: A Novel Mitotic Checkpoint Protein and Regulator of Tumorigenesis.

    abstract::Checkpoint with FHA and RING finger domains (CHFR) was first recognized as an early mitotic checkpoint protein that delayed the cell cycle in response to microtubule-targeting drugs. It is an E3 ubiquitin ligase that ubiquitinates target proteins to direct them to the proteasome for degradation or to alter their activ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.08109

    authors: Privette LM,Petty EM

    更新日期:2008-07-01 00:00:00

  • Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinoma.

    abstract:BACKGROUND:Oral squamous cell carcinoma (OSCC) remains a challenging cancer to treat despite all the advances of the last 50 years. Kallikrein 5 (KLK5) is among the serine proteases implicated in OSCC development. However, whether the activity of KLK5 promotes carcinogenesis is still controversial. Moreover, knowledge ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100970

    authors: Alves MG,Kodama MH,da Silva EZM,Gomes BBM,da Silva RAA,Vieira GV,Alves VM,da Fonseca CK,Santana AC,Cecílio NT,Costa MSA,Jamur MC,Oliver C,Cunha TM,Bugge TH,Braz-Silva PH,Colli LM,Sales KU

    更新日期:2021-01-01 00:00:00

  • Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma.

    abstract::CAP2 has been suggested as a potential diagnostic biomarker for early hepatocellular carcinoma (HCC). However, its prognostic significance in HCC remains unclear. Here, we show that CAP2 expression is much higher in HCC tissues than that in paracarcinoma tissues, at both mRNA and protein levels. Data of immunohistoche...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2015.08.003

    authors: Fu J,Li M,Wu DC,Liu LL,Chen SL,Yun JP

    更新日期:2015-10-01 00:00:00

  • Heterogeneous Drug Efficacy of an Antibody-Drug Conjugate Visualized Using Simultaneous Imaging of Its Delivery and Intracellular Damage in Living Tumor Tissues.

    abstract::Anticancer drug efficacy varies because the delivery of drugs within tumors and tumor responses are heterogeneous; however, these features are often more homogenous in vitro. This difference makes it difficult to accurately determine drug efficacy. Therefore, it is important to use living tumor tissues in preclinical ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100764

    authors: Gonda K,Negishi H,Takano-Kasuya M,Kitamura N,Furusawa N,Nakano Y,Hamada Y,Tokunaga M,Higuchi H,Tada H,Ishida T

    更新日期:2020-06-01 00:00:00

  • MicroRNA-506-3p increases the response to PARP inhibitors and cisplatin by targeting EZH2/β-catenin in serous ovarian cancers.

    abstract::Chemo-resistance is an important barrier to effective treatment of ovarian cancer. Poly (ADP-ribose) polymerase (PARP) inhibitors are currently promising targeted drugs used to treat BRCA-mutant ovarian cancer. Ovarian cancer patients with BRCA 1/2 mutations appear to benefit better from PARP inhibitors and chemothera...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100987

    authors: Sun Y,Wu J,Dong X,Zhang J,Meng C,Liu G

    更新日期:2021-02-01 00:00:00

  • Spatiotemporal Optoacoustic Mapping of Tumor Hemodynamics in a Clinically Relevant Orthotopic Rabbit Model of Head and Neck Cancer.

    abstract::The purpose of this study was to investigate the usefulness of photoacoustic imaging (PAI) for spatiotemporal mapping of tumor hemodynamics in a rabbit model of head and neck carcinoma. Shope cottontail rabbit papilloma virus associated VX2 carcinomas were established in adult male New Zealand White rabbits (n = 9) by...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.08.004

    authors: Rich LJ,Sexton S,Curtin L,Seshadri M

    更新日期:2017-10-01 00:00:00

  • Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease.

    abstract::Hormone receptor positive (HR+) breast cancers are a heterogeneous class with differential prognosis. Although more than half of Indian women present with advanced disease, many such patients do well. We have attempted identification of biologically indolent tumors within HR+HER2- tumors based on gene expression using...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.04.011

    authors: Prabhu JS,Korlimarla A,Anupama CE,Alexander A,Raghavan R,Kaul R,Desai K,Rajarajan S,Manjunath S,Correa M,Raman R,Kalamdani A,Prasad M,Patil S,Gopinath KS,Srinath BS,Sridhar TS

    更新日期:2017-08-01 00:00:00

  • Limitations of Anti-Angiogenic Treatment of Tumors.

    abstract::Clinical trials using anti-vascular endothelial growth factor /(VEGF) molecules induce a modest improvement in overall survival, measurable in weeks to just a few months, and tumors respond differently to these agents. In this review article, we have exposed some tumor characteristics and processes that may impair the...

    journal_title:Translational oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.tranon.2019.04.022

    authors: Ribatti D,Annese T,Ruggieri S,Tamma R,Crivellato E

    更新日期:2019-07-01 00:00:00

  • Osimertinib regressed an EGFR-mutant lung-adenocarcinoma bone-metastasis mouse model and increased long-term survival.

    abstract::Bone is one of the most frequent metastatic sites in non-small cell lung cancer (NSCLC). Osimertinib, with and without bevacizumab (BV), has been investigated on advanced NSCLC patients. However, the efficacy of those drugs on bone metastasis of NSCLC has not been investigated. The human NSCLC cell line H1975, express...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100826

    authors: Higuchi T,Sugisawa N,Park JH,Sun Y,Zhu G,Yamamoto N,Hayashi K,Kimura H,Miwa S,Igarashi K,Bouvet M,Singh SR,Tsuchiya H,Hoffman RM

    更新日期:2020-10-01 00:00:00

  • The association between monocytic myeloid-derived suppressor cells levels and the anti-tumor efficacy of anti-PD-1 therapy in NSCLC patients.

    abstract::Monocytic myeloid-derived suppressor cells (M-MDSCs), granulocytic MDSC (G-MDSCs) and regulatory T cells (Tregs) inhibit adaptive anti-tumor immunity and undermine the efficacy of anti-PD-1 therapy. However, the impact of anti-PD-1 treatment on these immunosuppressive cells has not been clearly defined in non-small ce...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100865

    authors: Feng J,Chen S,Li S,Wu B,Lu J,Tan L,Li J,Song Y,Shi G,Shi YG,Jiang J

    更新日期:2020-12-01 00:00:00

  • TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer.

    abstract::This study aimed to identify novel prognostic biomarker for advanced renal cell carcinoma (RCC) patients treated with anti-PD-1 therapy, using quantitative multi-immunofluorescence (IF) analysis of tumor immunity. Twenty-five consecutive patients who had metastatic or unresectable RCC treated with anti-PD-1 therapy we...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100918

    authors: Kato R,Jinnouchi N,Tuyukubo T,Ikarashi D,Matsuura T,Maekawa S,Kato Y,Kanehira M,Takata R,Ishida K,Obara W

    更新日期:2021-01-01 00:00:00

  • Prognosis of primary hepatic lymphoma: A US population-based analysis.

    abstract:OBJECTIVE:Primary hepatic lymphoma (PHL) is a rare malignancy with lesions confined to the liver. It is characterized by a large number of monomorphic, medium-sized lymphocytic infiltrates in the hepatic sinusoid. Due to the rarity of this malignancy, our current understanding of PHL is limited. METHODS:We collected i...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100931

    authors: Qiu MJ,Fang XF,Huang ZZ,Li QT,Wang MM,Jiang X,Xiong ZF,Yang SL

    更新日期:2021-01-01 00:00:00

  • Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile.

    abstract::Despite the weak clinical efficacy of TRAIL death receptor agonists, a search is under way for new agents that more efficiently activate apoptotic signaling. We previously created a TRAIL DR5-selective variant DR5-B without affinity for the DR4, DcR1, DcR2, and OPG receptors and increased proapoptotic activity in tumo...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100762

    authors: Yagolovich AV,Artykov AA,Karmakova TA,Vorontsova MS,Pankratov AA,Andreev-Andrievsky AA,Dolgikh DA,Kirpichnikov MP,Gasparian ME

    更新日期:2020-04-01 00:00:00

  • Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion.

    abstract::Wnt signaling has been implicated as a driver of prostate cancer-related osteoblast differentiation, and previous studies have linked modifications in Wnt function with the induction of tumor metastasis. A unique aspect of prostate cancer bone metastases in mouse models is their relative predilection to the hindlimb (...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100747

    authors: Wang Y,Singhal U,Qiao Y,Kasputis T,Chung JS,Zhao H,Chammaa F,Belardo JA,Roth TM,Zhang H,Zaslavsky AB,Palapattu GS,Pienta KJ,Chinnaiyan AM,Taichman RS,Cackowski FC,Morgan TM

    更新日期:2020-04-01 00:00:00

  • Oxidative DNA damage in the prostate may predispose men to a higher risk of prostate cancer.

    abstract::DNA damage has been associated with prostate cancer risk. Men who were referred for initial prostate biopsy for elevated prostate-specific antigen or abnormal digital rectal examination are often found with no cancer but have a higher risk of developing prostate cancer than the general population of men in their lifet...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.08217

    authors: Wu JD,Lin DW,Page ST,Lundgren AD,True LD,Plymate SR

    更新日期:2009-03-01 00:00:00

  • Combined Selection System to Lower the Cutoff for Plasma Cell Enrichment Applied to iFISH Analysis in Multiple Myeloma.

    abstract::Multiple myeloma (MM) is a very heterogeneous disease, characterized by multiple cytogenetic aberrations on plasma cells (PC) that have been traditionally used to predict the outcome of the disease. A mayor issue on the analysis of PC is the sometimes low infiltration of these cells in the bone marrow that hampers cyt...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.02.021

    authors: Mansilla C,Soria E,Vallejo M,Valiente A,Perez-Juana A,Zabalza A,Hurtado G,Sala F,Ramírez N

    更新日期:2018-06-01 00:00:00

  • A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer.

    abstract:PURPOSE:In the current study we examined the ability of diffusion MRI (dMRI) to predict pathologic response in pancreatic cancer patients receiving neoadjuvant chemoradiation. METHODS:We performed a prospective pilot study of dMRI in patients with resectable pancreatic cancer. Patients underwent dMRI prior to neoadjuv...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2014.07.005

    authors: Cuneo KC,Chenevert TL,Ben-Josef E,Feng MU,Greenson JK,Hussain HK,Simeone DM,Schipper MJ,Anderson MA,Zalupski MM,Al-Hawary M,Galban CJ,Rehemtulla A,Feng FY,Lawrence TS,Ross BD

    更新日期:2014-10-24 00:00:00

  • Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma.

    abstract::Receptor tyrosine kinases (RTKs) are membrane receptors that play a vital role in various biological processes, in particular, cell survival, cell proliferation, and cell differentiation. These cellular processes are composed of multitiered signaling cascades of kinases starting from ligand binding to extracellular do...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.08.005

    authors: Chaiyawat P,Klangjorhor J,Settakorn J,Champattanachai V,Phanphaisarn A,Teeyakasem P,Svasti J,Pruksakorn D

    更新日期:2017-10-01 00:00:00

  • Mining database for the expression and clinical significance of STAT family in head and neck squamous cell carcinomas.

    abstract:BACKGROUND:Head and neck squamous cell carcinomas (HNSC) are among the most common malignant tumors with high incidence, relapse, and mortality rate. STAT proteins are implicated in various biological processes, including cell proliferation, metastasis, and immune regulation. METHOD:Various bioinformatics tools were u...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100976

    authors: Ni H,Sun H,Zheng M,Bian T,Liu J,Li X,Zhang J,Liu Y

    更新日期:2021-01-01 00:00:00

  • Collaboration Between RSK-EphA2 and Gas6-Axl RTK Signaling in Arginine Starvation Response That Confers Resistance to EGFR Inhibitors.

    abstract::Many human malignancies require extracellular arginine (Arg) for survival because the key enzyme for de novo Arg biosynthesis, argininosuccinate synthetase 1 (ASS1), is silenced. Recombinant arginine deiminase (ADI-PEG20), which digests extracellular Arg, has been in clinical trials for treating ASS1-negative tumors. ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2019.12.003

    authors: Kuo MT,Long Y,Tsai WB,Li YY,Chen HHW,Feun LG,Savaraj N

    更新日期:2020-02-01 00:00:00

  • Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.

    abstract::BRAFV600-mutated colorectal cancer (CRC) accounts for 8% to 12% of all CRC diagnoses. These tumors are often associated with specific patient features, including right-sided primary tumor location, peritoneal and non-regional lymph node involvement, and poor prognosis. In approximately 30% of cases, a simultaneous mis...

    journal_title:Translational oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.tranon.2020.100795

    authors: Roviello G,D'Angelo A,Petrioli R,Roviello F,Cianchi F,Nobili S,Mini E,Lavacchi D

    更新日期:2020-09-01 00:00:00

  • MRI Texture Analysis Reflects Histopathology Parameters in Thyroid Cancer - A First Preliminary Study.

    abstract:OBJECT:Thyroid cancer represents the most frequent malignancy of the endocrine system with an increasing incidence worldwide. Novel imaging techniques are able to further characterize tumors and even predict histopathology features. Texture analysis is an emergent imaging technique to extract extensive data from an rad...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.09.003

    authors: Meyer HJ,Schob S,Höhn AK,Surov A

    更新日期:2017-12-01 00:00:00